AbbVie Inc/ US00287Y1091 /
2024-03-28 9:10:00 PM | Chg. +1.75 | Volume | Bid1:00:00 AM | Ask1:00:00 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
182.10USD | +0.97% | 5.42 mill. Turnover: 718.54 mill. |
181.65Bid Size: 100 | 183.84Ask Size: 100 | 321.67 bill.USD | 3.29% | 66.70 |
GlobeNewswire
03-25
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, In...
GlobeNewswire
03-25
Professional Diversity Network (PDN) Hosts Successful Virtual Career Fair for Women’s History Month
GlobeNewswire
03-25
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmu...
GlobeNewswire
03-25
Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Director...
GlobeNewswire
03-22
Gastroenterologists Slow to Adopt Eli Lilly’s Omvoh, Pfizer’s Velsipity, and Takeda’s subcutaneous ...
GlobeNewswire
03-18
CIO Celebrates Innovations in Business Technology with 2024 CIO 100 & Hall of Fame Awards
GlobeNewswire
03-11
Caribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Busines...
GlobeNewswire
03-11
Nitrase Therapeutics Unveils Pioneering Antibody Candidate for Parkinson’s Disease Based on Nitratio...
GlobeNewswire
03-09
Samsung Bioepis Presents Two Abstracts for Its Immunology Portfolio at the 2024 American Academy of ...
GlobeNewswire
03-05
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Trea...
GlobeNewswire
03-01
NurExone Presenting Novel Regulatory Pathways for Exosomes Therapies at Global Summit
GlobeNewswire
02-29
argenx Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
GlobeNewswire
02-28
Promising Pathways to Simplified Alzheimer's Diagnosis Unveiled in Groundbreaking Study
GlobeNewswire
02-27
Alector Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update